Scancell
SEARCH
  • HOME
  • COMPANY
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • PARTNERSHIPS
    • CAREERS
  • VACCINES
    • MODITOPE
      • Modi-1
      • Modi-2
    • IMMUNOBODY
      • SCIB1 & iSCIB1+
      • SCIB2 & iSCIB2
      • COVIDITY
    • VACCINE PUBLICATIONS
  • ANTIBODIES
    • GLYMAB
      • ANTI-GLYCAN MAB
    • AVIDIMAB
    • ANTIBODY PUBLICATIONS
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2022
    • YEAR - 2021
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US
SEARCH
  • NEWS
  • LATEST NEWS
  • HOME
  • COMPANY
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • PARTNERSHIPS
    • CAREERS
  • VACCINES
    • MODITOPE
      • Modi-1
      • Modi-2
    • IMMUNOBODY
      • SCIB1 & iSCIB1+
      • SCIB2 & iSCIB2
      • COVIDITY
    • VACCINE PUBLICATIONS
  • ANTIBODIES
    • GLYMAB
      • ANTI-GLYCAN MAB
    • AVIDIMAB
    • ANTIBODY PUBLICATIONS
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2022
    • YEAR - 2021
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US

Latest News

Modi-1 Phase 1/2 clinical trial open for recruitment

To download click here

April 13, 2022

Broadening of COVIDITY Phase 1 clinical trial in South Africa

To download click here

March 29, 2022

Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™

To download click here

March 17, 2022

Update on COVIDITY Phase 1 clinical trial in South Africa

To download click here

January 31, 2022

Interim Results for the 6 months ended 31 October 2021

To download click here

January 26, 2022

Results of AGM 2021

To download click here

November 24, 2021

View all posts »
  • Company
  • Overview
  • Board of Directors
  • Management
  • Partnerships
  • Careers
  • Vaccines
  • Moditope
  • Immunobody
  • Vaccine Publications
  • Antibodies
  • GlyMAb
  • AvidiMab
  • Antibody Publications
  • Investors
  • Company Profile
  • Advisors
  • Corporate Governance
  • Documents & Presentations
  • Share Information
  • Financial Information
  • Regulatory News
  • News
  • Latest News
  • Contact Us
  • Privacy

News updates

Sign up for news updates to stay up to date with Scancell

Privacy & legal notes ©Copyright Scancell 2022